CVE-2023-47254

Draytek Vigor167 Firmware command injection

9.8 CRITICALEPSS 2.20%

Published9 Dec 2023

Description

An OS Command Injection in the CLI interface on DrayTek Vigor167 version 5.2.2, allows remote attackers to execute arbitrary system commands and escalate privileges via any account created within the web interface.

CVSS 3.1 breakdown

Attack vectorNetwork

Attack complexityLow

Privileges requiredNone

User interactionNone

ScopeUnchanged

ConfidentialityHigh

IntegrityHigh

AvailabilityHigh

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H

Affected products

Draytek Vigor167 Firmware5.2.2

Remediation

No fixed version is recorded in the NVD data. Check the vendor advisory for the latest guidance.

Frequently asked

Is CVE-2023-47254 being actively exploited?

CVE-2023-47254 is not in the CISA KEV catalog. Its EPSS exploit probability is 2.20%.

How severe is CVE-2023-47254?

CVE-2023-47254 has a CVSS 3.1 base score of 9.8, rated critical. EPSS estimates a 2.20% probability of exploitation.

Which products are affected by CVE-2023-47254?

Affected products include Draytek Vigor167 Firmware.

How do I fix CVE-2023-47254?

Apply the vendor's patch or advisory guidance, then verify no affected versions remain across your devices.

How Secuno handles this

Secuno correlates vulnerabilities like CVE-2023-47254 against the real software inventory on every managed device, every day. Rather than a static severity, each match is scored in context: exploit availability, EPSS, the asset's exposure, and business criticality decide where it lands in the queue. If an affected version is present anywhere across your portfolio, it surfaces automatically with a prioritised remediation path.

See how prioritisation works Book a demo

Data from the NVD, CISA KEV catalog and FIRST EPSS. CVSS 3.1 base score shown where available.